Elevance Health kicked off 2025 by beating earnings expectations with an EPS of $11.97, flexing its operational muscles ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Elevance Health's Q1 results showed stable Medicare utilization and reaffirmed guidance. Click here to find out why ELV stock ...

The program now serves 6 million patients, and Elevance sees it as something that sets it apart from the competition.

Q1 2025 Earnings Call Transcript April 22, 2025 Elevance Health Inc. beats earnings expectations. Reported EPS is $11.97, ...

RBC Capital analyst Ben Hendrix maintained a Buy rating on Elevance Health (ELV – Research Report) today and set a price target of $478.00. The ...

In a report released today, Andrew Mok CFA from Barclays maintained a Buy rating on Elevance Health (ELV – Research Report), with a price ...

Elevance Health stands tall in the telehealth boom, showing off its 800,000 virtual visits like badges of medical honor. The ...

FDA-cleared CureSight™ therapy now reimbursed by Elevance Health, expanding access to effective digital treatment for lazy ...

Shares of Elevance Health Inc. ELV rallied 1.11% to $435.68 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 9.52% to ...

A new law firm focused on supporting health tech and digital health companies ... intellectual property and M&A. The firm was founded by Rebecca Gwilt and Kaitlyn O'Connor, who have more than ...

Indianapolis-based health Elevance Health’s board is recommending its investors reject a shareholder proposal that asks the health insurance company to provide a report and metrics on the ...